Search jobs 29-Jan-2021 Respiratory Inhaler Devices Market In-Depth Analysis, Growth Strategies and Comprehensive Forecast to 2030 | Future Market Insights
VALLEY COTTAGE, N.Y. – A recent market study published by Future Market Insights (FMI) on the Respiratory Inhaler Devices market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the respiratory inhaler devices market, growth prospects of the market are obtained with maximum precision.
The report features unique and salient factors that may make a huge impact on the development of the respiratory inhaler devices market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the respirato
By Reuters Staff
2 Min Read
BOGOTA (Reuters) - Colombian authorities have seized 27 boxes of the antiviral drug remdesivir from a woman at an airport in Cucuta who said the drugs were a coronavirus vaccine, officials said on Friday.
The boxes seized by police contained a version of the drug called Bemsivir with a value of $18,000 on the black market, Colombia’s tax and customs police (POLFA) said in a statement.
Bemsivir, produced by Beximco Pharmaceuticals Ltd, is a generic form of remdesivir, a COVID-19 treatment developed by Gilead Sciences Inc.
“During a routine check that was carried out on Thursday at the airport in Cucuta, the boxes with the medicine were found in the luggage of a woman who said it was the vaccine against COVID-19,” POLFA director Brigadier General Gustavo Franco said in a telephone interview.
28 January 2021 | 09:46am
StockMarketWire.com - Manufacturer of generic pharmaceutical Beximco Pharmaceuticals said it expected to see material difference in its annual results after report a rise in half-year profit on increased sales
For the six months ended 31 December 2020, pre-tax profit rose to £3.0 million taka (BDT) from 2,980 million as revenue grew to £14,400 million from £12,495 million.
Net sales increased 20.7% to BDT 7,474.3 million. Looking ahead, we maintain a positive outlook for FY21 and reiterate, in line with the announcement on 14 January 2021, that while the costings of our vaccine distribution have yet to be determined, we expect to see a positive material difference to the company s year-end results, the company said.
Thu, 28th Jan 2021 14:40
Beximco Pharmaceuticals Ltd - Bangladesh-based medicine manufacturer - Reports profit after tax of GBP19.4 million for six months ended December 30, up 30% from GBP15.5 million in the 2019 equivalent period. Net sales for the period increased 15% to GBP125.8 million from GBP112.6 million the prior year, with domestic sales up 17% to GBP113.6 million from GBP100.0 million and export sales down 3.2% to GBP12.2 million from GBP12.6 million. We have delivered strong results in the first half of the year that demonstrate the resilience of the business and reinforce our commitment to ensure an uninterrupted supply of medicines despite macroeconomic headwinds caused by the ongoing Covid-19 pandemic. Looking ahead, we maintain a positive outlook for financial 2021 and reiterate, in line with the announcement on January 14, that while the costings of our vaccine distribution have yet to be determined, we expect to see a positive material difference to the company
3-MIN READ
Vaccine Diplomacy: These Pandemic-hit Nations Have So Far Received Covid Jabs from India
Employees pack boxes containing vials of COVID-19 vaccine at the Serum Institute of India in Pune, India, on Jan. 21, 2021. (AP Photo/Rafiq Maqbool)
The World Health Organisation (WHO), which has repeatedly criticised vaccine nationalism by richer nations, has praised India s efforts.
FOLLOW US ON:
Prime Minister Narendra Modi in his address to the World Economic Forum s Davos Summit on Thursday said the world would receive more vaccines from India. The nation started its mega inoculation drive about a week back with Bharat Biotech s Covaxin and the Oxford-AstraZeneca vaccine produced by the Serum Institute of India.